These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from March 9 through March 15, 2023. Source: VerityData
Baker Brothers revealed a position in the biopharmaceutical firm of 47,233,651 shares, inclusive of 71,887 and 1,503 shares underlying stock options and restricted stock units, respectively.